These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Phosphorylation of 5-iodo-5'-amino-2',5',dideoxyuridine by herpes simplex virus type 1 encoded thymidine kinase. Chen MS, Prusoff WH. J Biol Chem; 1979 Oct 25; 254(20):10449-52. PubMed ID: 226542 [Abstract] [Full Text] [Related]
11. The relationship between the antiviral activity of 5'-amino-5'-deoxythymidine and its incorporation into herpes simplex virus type 1 DNA. Otto MJ, Prusoff WH. Antiviral Res; 1984 Oct 25; 4(5):271-80. PubMed ID: 6097180 [Abstract] [Full Text] [Related]
12. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Shimizu K, Seno T. Mol Pharmacol; 1987 Sep 25; 32(3):410-6. PubMed ID: 2823092 [Abstract] [Full Text] [Related]
13. The relationship between incorporation of E-5-(2-Bromovinyl)-2'-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity. Mancini WR, De Clercq E, Prusoff WH. J Biol Chem; 1983 Jan 25; 258(2):792-5. PubMed ID: 6296080 [Abstract] [Full Text] [Related]
14. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro. Fischer PH, Lee JJ, Chen MS, Lin TS, Prusoff WH. Biochem Pharmacol; 1979 Dec 01; 28(23):3483-6. PubMed ID: 231443 [No Abstract] [Full Text] [Related]
15. Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells. Allaudeen HS, Chen MS, Lee JJ, De Clercq E, Prusoff WH. J Biol Chem; 1982 Jan 25; 257(2):603-6. PubMed ID: 6274855 [Abstract] [Full Text] [Related]
16. Topical therapeutic efficacy of 9-(2-hydroxyethoxymethyl)guanine and 5-iodo-5'-amino-2',5'-dideoxyuridine on oral infection with herpes simplex virus in mice. Park NH, Pavan-Langston D, Hettinger ME, McLean SL, Albert DM, Lin TS, Prusoff WH. J Infect Dis; 1980 May 25; 141(5):575-9. PubMed ID: 6966305 [Abstract] [Full Text] [Related]
17. Effect of incorporation of 5-iodo-2'-deoxyuridine into HSV-1 DNA on virion sensitivity to ultraviolet light. Zucker ML, Prusoff WH. Biochem Pharmacol; 1987 Oct 15; 36(20):3471-6. PubMed ID: 2823822 [Abstract] [Full Text] [Related]
19. Antiviral activity of 5-iodo-2'-deoxyuridine and related drugs in human keratinocytes infected in vitro with herpes simplex virus type 1. Reuveni H, Bull CO, Landry ML, Milstone LM, Schwartz PM. Skin Pharmacol; 1991 May 15; 4(4):291-7. PubMed ID: 1665069 [Abstract] [Full Text] [Related]
20. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene. Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Seno T. Mol Pharmacol; 1985 Dec 15; 28(6):581-7. PubMed ID: 3001499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]